August 17 (SeeNews) - The net profit of Romanian state-controlled drug maker Antibiotice [BSE:ATB] rose 17% year-on-year in the first six months of 2017, reaching 19.2 million lei ($4.9 million/4.1 million euro), the company said on Thursday.